China Pharma Holdings (CPHI) Gross Margin (2010 - 2026)
China Pharma Holdings (CPHI) posted Gross Margin of 29.03% for Q1 2026, up 136.02% on a QoQ basis from 12.3% in Q4 2025, and up 4100.0% year-over-year from 0.69% in Q1 2025.
China Pharma Holdings (CPHI) Gross Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings' Gross Margin history runs 17 years deep, the most recent figure standing at 29.03% for Q1 2026.
- Quarterly Gross Margin rose 4100.0% year-over-year to 29.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.26% (up 4990.0% YoY) and the FY2025 annual result came in at 3.18%, up 4066.0% from the prior year.
- Gross Margin was 29.03% for Q1 2026 at China Pharma Holdings, up from 12.3% in the prior quarter.
- Across five years, Gross Margin topped out at 29.03% in Q1 2026 and bottomed at 109.78% in Q2 2024.
- A 5-year average of 13.56% and a median of 10.56% in 2022 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin plunged 9642 bps — and 2025, when it soared 10130 bps.
- China Pharma Holdings' Gross Margin stood at 1.46% in 2022, then sank by 352 bps to 3.68% in 2023, then sank by 285 bps to 14.16% in 2024, then jumped by 187 bps to 12.3% in 2025, then surged by 136 bps to 29.03% in 2026.
- Business Quant data shows CPHI's Gross Margin at 29.03% in Q1 2026, 12.3% in Q4 2025, and 7.89% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | 29.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.03% |
| Dec 31, 2025 | 12.30% |
| Sep 30, 2025 | -7.89% |
| Jun 30, 2025 | -8.48% |
| Mar 31, 2025 | -11.97% |
| Dec 31, 2024 | -14.16% |
| Sep 30, 2024 | -47.23% |
| Jun 30, 2024 | -109.78% |
| Mar 31, 2024 | -21.17% |
| Dec 31, 2023 | -3.68% |
| Sep 30, 2023 | -12.93% |
| Jun 30, 2023 | -13.36% |
| Mar 31, 2023 | 9.08% |
| Dec 31, 2022 | 1.46% |
| Sep 30, 2022 | -7.01% |
| Jun 30, 2022 | -14.22% |
| Mar 31, 2022 | -10.56% |
| Dec 31, 2021 | 10.45% |
| Sep 30, 2021 | -14.98% |
| Jun 30, 2021 | 2.94% |